FeesSafety
Pluang+

WRAP appoints Eric Bowen as COO to scale its non-lethal response business and drive operational execution.

Market News
10 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
WRAP appoints Eric Bowen as COO to scale its non-lethal response business and drive operational execution.

WRAP Technologies has named Eric Bowen as Chief Operating Officer to lead operational execution and scale its non-lethal response business, including the BolaWrap 150 device and training programs. Bowen brings extensive experience from national security tech firms and will focus on building repeatable, scalable delivery and recurring revenue models. This leadership move supports WRAP's strategy to grow its core business and advance new technologies like WrapShield. The company aims to convert regulatory and training foundations into commercial success with Bowen overseeing operations and Jared Novick focusing on revenue and partnerships.

WRAP Technologies' appointment of Eric Bowen as COO provides context for readers following technology firms. For readers following technology stocks, here is Pluang's market snapshot as of Nov 10, 2026 18:12 WIB: out of 150 priced US technology stocks, 51 rose and 89 fell. ASX traded at USD 36.43 with a 1-day change of +6.02%, while WIX was priced at USD 66.74 with a -4.32% change.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
59 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
59 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
59 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
59 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App